---
title: "Chinese scientists have discovered that a migraine medication is expected to aid in the immunotherapy of triple-negative breast cancer"
type: "News"
locale: "zh-CN"
url: "https://longbridge.com/zh-CN/news/275193868.md"
description: "The Breast Tumor Center of Fudan University Affiliated Tumor Hospital, in collaboration with the research team of the Fudan University Institute of Brain Science, discovered that sensory nerves in tumors are the \"culprit\" causing some triple-negative breast cancer patients to develop resistance to immunotherapy in the short term, and found that a drug used to treat migraines can enhance the sensitivity to immunotherapy. The related results were published on the 6th in the international academic journal \"Cell.\" (Xinhua News Agency)"
datetime: "2026-02-07T06:02:19.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/275193868.md)
  - [en](https://longbridge.com/en/news/275193868.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/275193868.md)
---

> 支持的语言: [English](https://longbridge.com/en/news/275193868.md) | [繁體中文](https://longbridge.com/zh-HK/news/275193868.md)


# Chinese scientists have discovered that a migraine medication is expected to aid in the immunotherapy of triple-negative breast cancer

The Breast Tumor Center of Fudan University Affiliated Tumor Hospital, in collaboration with the research team of the Fudan University Institute of Translational Neuroscience, discovered that sensory nerves in tumors are the "culprit" causing some triple-negative breast cancer patients to develop resistance to immunotherapy in the short term, and found that a drug used to treat migraines can enhance the sensitivity to immunotherapy. The related results were published on the 6th in the international academic journal "Cell." (Xinhua News Agency)

## 相关资讯与研究

- [Paper-Based Honeycomb Transit Packaging Market Forecast 2026-2036: Global Market to Reach USD 2.6 Billion by 2036 at 8.0% CAGR](https://longbridge.com/zh-CN/news/279036605.md)
- [Dr. Reddy’s Flags Phase III Setback as Immutep Halts Key Lung Cancer Trial](https://longbridge.com/zh-CN/news/279076056.md)
- [IR Japan Denies Decision to End SMBC Trust Bank Alliance](https://longbridge.com/zh-CN/news/278972282.md)
- [PayPay Stock Surges Amid Post-IPO Fluctuations](https://longbridge.com/zh-CN/news/279072293.md)
- [ANALYSIS-New Target CEO slashes prices. Previous cuts offered short-lived sales boost.](https://longbridge.com/zh-CN/news/279021859.md)